FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.12.31
Overview: LEADS BIOLABS-B(09887) the Revenue is 197.11 M (--%), Miss estimate;the EBIT is -216.32 M (--%), Miss estimate;the EPS is -1.35 (+37.07%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.20B--
0.25B--
-0.05B--%
EBITMiss expectations
-0.22B--
-0.18B--
-0.04B--%
EPSMiss expectations
-1.345637.07%
-1.199343.92%
-0.14636.85%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf